Endocrinology Vol. 142, No. 10 4515-4521
Copyright © 2001 by The Endocrine Society
Eotaxin Is Required for Eosinophil Homing into the Stroma of the Pubertal and Cycling Uterus
Valérie Gouon-Evans and
Jeffrey W. Pollard
Departments of Developmental and Molecular Biology (V.G.-E.,
J.W.P.), Obstetrics & Gynecology and Womens Health (J.W.P.) and
Center for the Study of Reproductive Biology and Womens Health,
Albert Einstein College of Medicine, New York, New York 10461
Address all correspondence and requests for reprints to: Jeffrey W. Pollard, Ph.D., Albert Einstein College of Medicine, Department of Developmental and Molecular Biology, 1300 Morris Park Avenue, Bronx, New York 10461. E-mail: pollard{at}aecom.yu.edu
 |
Abstract
|
|---|
The presence of eosinophils in the endometrium of rodents during
the estrous cycle or after E2 administration to ovariectomized animals
is well documented. Nevertheless, the chemoattractant for eosinophils
and the function of E-dependent eosinophils during the estrous cycle
remain unknown. Using mice homozygous for a null mutation in the gene
for eotaxin, a specific chemokine for eosinophils, we have identified
eotaxin as being necessary for eosinophil homing into the uterine
stroma, and regulated by E2 during the estrous cycle. In the absence of
eosinophils, the onset of estrous cycle displayed a 2-wk delay along
with the first age of parturition, suggesting a possible local role of
eosinophils present in the pubertal uterus in preparing the mature
uterus for pregnancy. However, despite the absence of eosinophils, once
the mice reach maturity, their estrous cycles as well as their
reproductive functions were normal. Our results demonstrate that E2
acts through eotaxin to recruit eosinophils to the uterine stroma
during the estrous cycle in mice, but that these cells do not have a
function in regulating either the duration of the estrous cycle or
fertility of mice.
 |
Introduction
|
|---|
DURING THE ESTROUS cycle, the heterogeneous
cell types of the uterus undergo continuous synchronized waves of
proliferation, differentiation, and recruitment in response to the rise
and fall of E2 and progesterone (1, 2). Serum E2 levels
increase at proestrus to stimulate proliferation of the epithelial
compartment. When the serum E2 level drops at estrus, the luminal and
glandular epithelial cells undergo apoptosis to return to original cell
number (2, 3). Along with the induction of epithelial cell
proliferation, E2 is also responsible for recruitment of inflammatory
leukocyte cells from the blood stream into the stromal compartment
(4, 5). Macrophages, MHC class II
dendritic
cells, eosinophils, and neutrophils are the predominant leukocytes
homing to the cycling uterus (6, 7, 8, 9, 10, 11).
Considerable literature exists showing that eosinophils infiltrate
cyclically the rodent uterus. Infiltration of the rat uterus by
eosinophils, coincident with the estrus cycle (12), was
observed during the 1950s, and this observation has been confirmed and
extended to different species such as mouse and human (9, 10, 13, 14). Since then, numerous investigations have shown that: 1)
injection of E2 into ovariectomized or immature rodents causes a
dramatic increase in uterine eosinophils (5) and an
increase in uterine peroxidase activity (15) that was
shown later to be restricted to eosinophils (16, 17); 2)
uterine eosinophil numbers vary more than 100-fold during the normal
estrous cycle (18); 3) eosinophils undergo lysis in the
uterus around the time of estrus releasing their contents into the
extracellular spaces (10, 19); and 4) the E-induced
uterine eosinophilia is associated with marked uterine edema
(20). Despite the fact that eosinophil homing into the
cycling uterus is well established, the role of these cells and their
chemoattractant remain to be elucidated.
Of the cytokines implicated in modulating eosinophilic inflammation,
only IL-5 and eotaxin have been identified to selectively regulate
eosinophil trafficking (21, 22, 23). IL-5 is responsible for
the proliferation, differentiation, recruitment, and activation of
eosinophils. Studies in mice lacking IL-5 caused by passive
immunization against IL-5 or by the generation of a null mutation of
the IL-5 gene showed that these mice are virtually devoid of
eosinophils in the blood stream and that consequently their uterine
eosinophil population was depleted strongly (24, 25, 26).
Nevertheless, these studies did not demonstrate the physiological
chemoattractant effect of IL-5 for eosinophil homing from the blood
stream into the uterus. Eotaxin, a member of the C-C chemokine family,
has been originally identified as a novel chemotactic agent for
eosinophils into the lung in a guinea pig model of eosinophilic airway
hypersensitivity (22). Eotaxin mRNA is induced in multiple
animal models of eosinophilic inflammation, in human tissue in response
to allergen challenge (23, 27, 28), and also in the mouse
mammary gland during postnatal development (29). Recently,
the expression of eotaxin and its receptor have been reported in human
endometrium through the menstrual cycle (30). However, the
functions of eotaxin during the estrus cycle remain unknown.
The purpose of this study was to examine the uterine eosinophil
population in eotaxin-deficient mice and determine the physiological
importance of eotaxin and eotaxin-dependent eosinophils in
reproduction.
 |
Materials and Methods
|
|---|
Animals and injection schedule for estimation of E2
responsiveness
Eotaxin-deficient mice maintained on an inbred 129/SvEv
background were a kind gift from Dr. Marc E. Rothenberg (Division of
Pulmonary Medicine, Allergy and Clinical Immunology, Childrens
Hospital Medical Center, Cincinnati, OH) (31). 129/SvEv
wild-type and mutant mice were mated under pathogen-free conditions in
a barrier facility at the Albert Einstein College of Medicine. All
studies were performed under NIH guidelines for the care and treatment
of experimental laboratory rodents.
The onset of puberty was assessed in two ways: 1) vaginal opening and
2) the onset of complete estrous cycles (two cycles). Mice were
examined daily from 4 wk of age to determine whether vaginal opening
had occurred. Analysis of estrous cycles was performed from 5 wk of
age. Vaginal smears were obtained on a daily basis, stained with
hematoxylin/eosin, and examined for cellular content. Four stages of
the cycle were defined as followed: proestrus (100% intact and alive
epithelial cells), estrus (100% cornified epithelial cells), metestrus
(
50% cornified epithelial cells and 50% leukocytes), and diestrus
(80100% leukocytes). For determination of the age of first
parturition, seven females of each group were mated with males from the
same group from 6 wk of age, and the age of the first parturition was
determined. Successful pregnancy interval was also determined in weeks
by mating nine wild-type females and eight mutant female with males
from the same group. The male was maintained with the female from the
mating period to d 2 after parturition, then separated, and finally
replaced with the female when the weaning period occurred (3 wk after
parturition). Interval times between two successful pregnancies were
noted for two to six consecutive pregnancies for each female per
group.
Adult female mice (1012 wk) were bilaterally ovariectomized on d 1,
primed at d 7 and d 8 by sc injection of 100 ng of E2 in 0.1 ml of
peanut oil, and then treated with 3 consecutive sc injections of 100 ng
of E2 in 0.1 ml of peanut oil at d 15, 16, and 17, or with 0.1 ml of
peanut oil for the control mice. Mice were killed 24 h or 42
h after the last injection, and uteri removed for analysis. The wet
weight of uteri in gram was measured for 68 mice of each group, and
statistical evaluations using standard deviations were performed with a
two-tailed t test.
Histochemistry
Uteri were fixed overnight in formalin (Sigma, St.
Louis, MO) and paraffin wax embedded for hematoxylin/eosin staining, or
OCT embedded (Tissue Tek; Bayer Corp., Elkart, IN)
and frozen for peroxidase activity analysis. Five-micrometer paraffin
sections were consecutively stained with hematoxylin and lightly with
eosin Y to identify eosinophils by their pink cytoplasmic granules and
segmented nucleus. Five-micrometer frozen sections were used to
detect the endogenous peroxidase activity restricted to eosinophils in
uterine tissue (17). Briefly, frozen sections were fixed
in acetone at 4 C for 10 min, rinsed in PBS, and then incubated for
25 min at room temperature in diaminobenzidine in presence of
hydrogen peroxide in a ratio determined by the Vector Laboratories, Inc. peroxidase kit (Burlingame, CA). Sections
were finally rinsed in water and counterstained with hematoxylin.
Northern blot analysis
Total RNA from uteri of one to three mice from each group
was isolated by the method of Chomczynski and Sacchi (32).
Ten micrograms of total RNA was separated by formaldehyde-agarose gel
electrophoresis, transferred to nylon filters, and probed with a
[32P]dCTP-labeled cDNA probe for eotaxin
[ATCC (Manassas, VA) No. 1463042; GenBank accession no.
AA711712] using the method previously described (33).
Western blot analysis
Each individual uterus was homogenized in RIPA buffer (9.1
mM dibasic sodium phosphate, 1.7 mM monobasic
sodium phosphate, 150 mM NaCl, 1% Nonidet P-40, 0.5%
sodium deoxycholate, 0.1% SDS, pH 7.4), and protein concentration
determined by a BCA protein assay (Pierce Chemical Co.,
Rockford, IL). Equal amount of protein (80 µg) under reducing
conditions were separated by electrophoresis on 15% SDS-polyacrylamide
gels and transferred onto polyvinylidendifluoride Immobilon-P membranes
(0.45 µm; Millipore Corp., Bedford, MA). The membranes
were blocked with 5% nonfat dry milk and 0.1% Tween 20 in
Tris-buffered saline (TBS: 150 mM NaCl, 20 mM
Tris, pH 7.6) for 1 h at RT. They were then incubated with the
IgG-purified rabbit antimurine eotaxin antibody (generously provided by
Dr. Steven Kunkel, University of Michigan, Ann Arbor, MI) at 0.5
µg/ml in blocking solution for 1 h at RT, washed 3 times for 15
min in TBS-Tween buffer, and subsequently incubated with a 1:3,000
dilution of horseradish peroxidase-linked secondary antibody
(Santa Cruz Biotechnology, Inc., Santa Cruz, CA) for 45
min at RT. After washing with TBS-Tween, immunodetection was achieved
with an enhanced chemiluminescence system (ECL; Amersham Pharmacia Biotech, Piscataway, NJ). Recombinant murine eotaxin
(Chemicon International Inc., Temecula, CA) was used as a reference
control and an
-guanine nucleotide dissociation inhibitor (GDI) (a
gift from Dr. Perry Bickel, Washington University, St. Louis, MO) was
used as internal control for protein abundance.
 |
Results
|
|---|
Eotaxin-dependent eosinophils in the pubertal and cycling
uterus
Eosinophil invasion of the uterine stroma during the estrous
cycle is well documented. However, the chemoattractant agent for these
cells has not been identified. Because eotaxin is a specific chemokine
for eosinophils and usually acts as a local chemoattractant, we
examined its transcript levels in the uterus. Eotaxin transcripts were
detected as early as 3 wk of age and throughout the pubertal uterine
development at 5 wk of age (Fig. 1A
). In
the adult, they were elevated during proestrus (P) returning to a
significantly lower level at diestrus (D) (P = 0.0004,
two-tailed t test) (Fig. 1B
). In ovariectomized mice,
transcript levels of eotaxin were almost undetectable, but they were
induced dramatically by E2 treatment, 39-fold at 24 h and 31-fold
at 42 h after injection (Fig. 1C
, top and bottom
panels). As predicted from the size of the eotaxin cDNA, the major
mRNA transcript was about 1 kb. It is of interest that in the adult
uterus but not in the peripubertal uterus, smaller transcripts were
systematically detected with a major one at 0.6 kb after E2 stimulation
either during the estrous cycle (Fig. 1B
) or following E2 treatment of
ovariectomized mice (Fig. 1C
). In the latter case, the induction of the
0.6-kb transcript paralleled perfectly the induction of the larger
transcript, although it was virtually undetectable in the untreated
ovariectomized uterus (Fig. 1C
, bottom panel). Even though
this smaller transcript has never been described in mice, it has been
reported in certain human tissues such as the small intestine, colon,
and heart (28). The nature of the 0.6-kb transcript is not
certain, but is sufficiently large to encode the 8.4-kDa eotaxin
protein and may represent use of an alternative polyadenylation site
(34). The eotaxin protein levels from total uterine
homogenates during the estrous cycle were analyzed in parallel to the
transcript levels by Western blot analysis using an anti-murine eotaxin
antibody. A band at approximately 8 kDa, which corresponded to the
reference control protein, indicated the presence of mouse eotaxin in
the uterus. Interestingly, eotaxin protein was only detected during the
proestrus phase (P/E), which was in this case at late proestrus, a
stage of maximal transcript expression. The inability to detect protein
in estrus or diestrus may reflect the sensibility of the antibody or
rapid degradation of the protein.

View larger version (45K):
[in this window]
[in a new window]
|
Figure 1. Eotaxin mRNA and protein levels in the
uterus. Northern Blot analysis of eotaxin mRNA transcript levels in
total uterine RNA from wild-type mice at 3 and 5 wk of age (A), during
the estrous cycle (P, proestrus; E, estrus; D, diestrus) (B), and after
E2 treatment following ovariectomy (C). Each lane contains the total
uterine RNA from 1 mouse. Uniformity of RNA loading is shown by
ethidium bromide staining of 28S rRNA (bottom panels).
Arrows point to the 1-kb and 0.6-kb transcripts. Means
of the global induction of both large and small transcripts during the
estrous cycle are significantly different between P and D
(P = 0.0004, two-tailed t test).
After E2 treatment, means of intensity of both 1 kb and 0.6 kb eotaxin
transcript levels are represented in the graph (mean ±
SEM), as well as the fold number of the global induction of
both large and small transcripts (C) (*/** significant differences
between the control no E2 and E2-treated samples, *
P = 0.0431 ** P = 0.0035,
two-tailed t test). Western blot analysis (D) of eotaxin
protein levels in total uterine protein extracts from wild-type mice
during the estrous cycle (P/E: advanced proestrus, beginning of E,
estrus; D, diestrus). Each lane contains the uterine homogenate from
one mouse. The membrane was also probed with the anti-GDI antibody as a
protein loading control. Eot, 10 ng recombinant murine eotaxin
control.
|
|
Two independent histologic methods were performed to detect
eosinophils in the uterus: hematoxylin/eosin staining, revealing the
eosin-positive cytoplasmic granules and the multilobular nucleus of
eosinophils, and the detection of endogenous peroxidase activity that
has been previously shown to be restricted to eosinophils in uterus
(16, 17). In pubertal mice, at 5 wk of age, eosin-positive
granule containing polynuclear eosinophils were highly recruited into
the uterine stroma of wild-type mice (Fig. 2A
), whereas they were totally absent in
eotaxin-deficient mice (Fig. 2B
). In adult mice, eosinophil recruitment
was analyzed following E2 treatment of ovariectomized mice. In
untreated mice, eosinophils were virtually absent (data not shown).
However, in confirmation of previous studies (5, 15), upon
E2-stimulation, the number of eosin-positive or peroxidase-positive
eosinophils increased gradually, reaching the highest number at a time
corresponding to an experimental estrus (determined by vaginal smear)
in wild-type mice 42 h after E2 treatment (Fig. 2
, C, E, and F).
Eosinophils were recruited into the uterine stroma in the vicinity of
the luminal epithelium (Fig. 2
, C and E) and in the myometrium
surrounding the stroma (Fig. 2F
). In contrast, no eosin-positive or
peroxidase-positive eosinophils could be seen in the uterus of
eotaxin-deficient mice at the experimental estrus at any location (Fig. 2
, D and G). Thus, eotaxin transcript level correlates with the
recruitment of eosinophils into the uterus of the pubertal and adult
mice. It is of interest to note that eotaxin protein is detected early
during the estrous cycle at proestrus when eosinophil homing into the
uterus begins, whereas the protein is undetectable by Western blot at
estrus at the time when eosinophil recruitment is the highest. This
suggested that eotaxin is an early signal for eosinophil homing into
the uterine stroma. In the absence of eotaxin, eosinophils are
completely absent at every stage of development.

View larger version (186K):
[in this window]
[in a new window]
|
Figure 2. Effect of the lack of eotaxin on eosinophil
populations in the uterus. AD, Hematoxylin/eosin staining of
endometrial cross-sections from wild-type +/+ (A, C) and
eotaxin-deficient -/- (B, D) mice at 5 wk of age (A, B) and in adult
ovariectomized mice 42 h after E2 treatment (C, D). Most of the
eosinophils are indicated with arrowheads. EG,
Eosinophil peroxidase activity (dark brown coloration)
detected on frozen uterine cross-section of wild-type (E, F) and mutant
(G) adult ovariectomized mice 42 h after E2 treatment. (E, G)
Endometrium; (F) Endometrium and Myometrium. Note the absence of
eosinophils in mutant mice shown by the lack of eosin staining and
eosinophil specific-peroxidase activity. *, Luminal epithelium.
Original magnification: AD, 1000x; EG, 250x.
|
|
Together these data indicate that eotaxin is the E-regulated chemokine
required for eosinophil recruitment in both pubertal and the cycling
uterus. Consequently, the eotaxin-deficient mouse is a useful model to
study the role of eosinophils in uterine development.
Reproductive phenotypes of eotaxin-deficient mice
Because of the early presence of eosinophils in the uterus of
pubertal mice, we examined the consequence of their absence on pubertal
uterine development, as well as on the onset of puberty and on the
reproductive functions of eotaxin-deficient mice.
The number of uterine glands is a useful parameter to evaluate
the maturation of uterine morphogenesis upon puberty (35).
The number of glands was enumerated in uterine cross-sections of
wild-type and mutant 5-wk-old mice. The gland number was similar in
both groups, indicating that the morphologic development of the uterus
of mutant mice seemed normal (Fig. 3A
).
Vaginal opening, as one measure of the onset of puberty, was examined,
and found to occur at a similar age in both groups between 4.55 wk of
age. The age of the onset of estrous cycle was next determined by
analyzing hematoxylin/eosin staining of daily vaginal smears starting
from 5 wk. Once the estrus phase was followed by metestrus, diestrus,
and proestrus phases, the estrous cycle was considered established. The
first estrous cycle started at 8.6 ± 0.2 wk in eotaxin-deficient
mice, significantly delayed by 2 wk compared with 6.6 ± 0.2 wk in
wild-type mice (Table 1
). The age of
first pregnancy was assessed by mating seven females from each group at
the age of 6 wk and by determining the age of their first parturition.
Consistent with the delay in the onset of estrous cycle, the age of the
first parturition was significantly delayed by 2 wk in the mutant mice
occurring at 11.3 ± 1.5 wk of age compared with 9.7 ± 1.6
wk of age in wild-type mice (Fig. 3B
). However, once the onset of
puberty occurred in mutant mice, the estrous cycle was not disturbed,
and it displayed a normal length compared with wild-type mice (Table 1
). Consequently, once mice reached adulthood, the reproduction
function of eotaxin-deficient females was normal with similar litter
size and interval time between consecutive successful pregnancies
compared with wild-type mice (Table 1
).

View larger version (22K):
[in this window]
[in a new window]
|
Figure 3. Effect of the lack of uterine eosinophils on the
stromal gland formation, the age of the first parturition and on
uterine edema. A, Uterine glands were enumerated in cross sections of
the upper third part of uteri from wild-type (+/+) and mutant (-/-) 5
wk of age mice after hematoxylin staining. Bars indicate
the mean ± SD from six mice per group. No statistical
difference was found (two-tailed t test). (B) The age of
the first parturition was assessed by mating seven females of each
group at the age of 6 wk with males from the same genotype. The age of
parturition in weeks was defined by the day one of the litter birth.
Each triangle represents the age of one female (*,
significant difference between genotypes; P =
0.0158, two-tailed t test). C, Uterine edema was assayed
by measuring the uterine wet weight. Six to eight mice of each genotype
ovariectomized at 1012 wk of age were treated with E2 three times for
3 d consecutively and killed 24 h (corresponding to an
experimental proestrus) or 42 h (corresponding to an experimental
estrus) after the last injection. Control mice (CTL) were
ovariectomized but not E2 treated. Wet weight of the entire uteri was
measured in gram. Bars indicate the mean ±
SD from three different experiments. No statistical
difference was found between two groups (two-tailed t
test).
|
|
Eosinophil recruitment is concurrent with the E-induced edema
during the estrous cycle, leading the suggestion that they may mediate
this edema (20). Thus, the effect of the lack of
eosinophils on the physiologic fluid accumulation occurring at
proestrus and estrus was examined. Uterine edema was experimentally
mimicked by reconstituting the estrogenic hormonal environment in
ovariectomized mice as indicated in Materials and Methods.
Wet uterine weight, which is commonly considered as an accurate
parameter for edema (2, 20, 36), was measured at different
time points after estrogenic stimulation. The E2 treatment
reconstituted perfectly proestrus and estrus as assessed by vaginal
smear analysis after 24 h and 42 h, respectively, in both
wild-type and mutant mice. After E2 treatment, the wet uterine weights
increased similarly and significantly compared with their respective
control (P < 0.0001 for both genotypes, two-tailed
t test). However, no difference of water imbibition was seen
in eotaxin-deficient mice at both experimental-proestrus and -estrus
compared with wild-type mice, indicating that the lack of eosinophils
did not affect E-induced edema (Fig. 3C
).
Our data demonstrate that even though eosinophils influence uterine
development upon the onset of puberty, the lack of eosinophils does not
affect the cycling uterus and hence the reproductive functions of the
adult mutant mice. These data suggest that eosinophils are not required
for the proper development of the cycling uterus.
 |
Discussion
|
|---|
Eosinophil invasion of the uterine stroma during the estrous cycle
is well documented. It is also well accepted that the infiltration of
eosinophils into the cycling uterus requires E2 stimulation (10, 16, 17). However the E-dependent chemoattractant agent for these
cells has not been identified. In this study, we have demonstrated that
it is eotaxin.
A previous study has shown the existence in the immature rat uterus of
an eosinophil chemotactic factor (ECF-U) whose synthesis is E2 receptor
mediated (37). After isolation and characterization of
uterine proteins displaying eosinophil chemoactivity, an amino acid
sequence analysis indicated that one of these proteins could be
cyclophilin, a protein that specifically binds cyclosporin A
(38). Obviously ECF-U/cyclophilin may contribute to the
uterine eosinophil infiltration; nevertheless there is no evidence
showing that they are necessary for this purpose. In the present study,
we demonstrate clearly that eotaxin is the chemokine necessary for
uterine eosinophil recruitment. It may be that eotaxin is in fact
ECF-U, because the apparent molecular mass of mouse eotaxin under
nonreducing condition is 17 kDa, similar to the 20-kDa rat ECF-U.
However, because cyclophilin is a peptidyl propyl-isomerase that can
act as a chaperone (39), it may be that eotaxin copurifies
with it under nonreducing conditions. Eotaxin also meets the
E-dependent requirement of the expected uterine eosinophil chemofactor
because its mRNA level is dramatically induced in ovariectomized mice
after E2 treatment. Moreover, both eotaxin protein and mRNA are
detected at proestrus, when eosinophil homing into uterus begins. Our
findings are consistent with the detection of eotaxin messengers by
RT-PCR at estrus in mice (40) and detection of eotaxin
protein in human endometrium (30).
Among the known eosinophil chemotactic factor, IL-5 was also considered
as a candidate acting in the uterus. Although the eosinophil population
was strongly depleted in the blood of IL-5-deficient mice, the temporal
fluctuations in eosinophil infiltration and localization in the uterine
stroma exhibited by the small residual population was unchanged in the
IL-5-deficient mice during the estrous cycle
(26). Moreover, the coadministration of the monoclonal
antibody anti-IL-5 with E2 to ovariectomized mice did not affect the
increase in the eosinophil chemotactic activity in the mouse uterus
(25). Therefore, it seems that the uterus illustrates a
cooperative and not synergistic role of IL-5 and eotaxin in recruiting
eosinophils in a specific organ, which has been previously reported in
other systems such as lung and skin (41, 42). These
observations agree with the notion that IL-5 provides the signal for
the release of a pool of eosinophils from the bone marrow, whereas
eotaxin remains the critical local chemoattractant for E-dependent
recruitment of eosinophils into the uterine stroma.
The eotaxin-deficient mouse, as a uterine eosinophil-free mouse, was
therefore a useful model to study the role of eosinophils in uterine
development. In these mice, eosinophils are at normal levels in the
bone marrow and peripheral blood (31, 43). Moreover, the
overexpression of IL-5 transgene is associated with an increased level
of gastrointestinal eosinophils in the absence of eotaxin
(43). Consequently, impaired eosinophil homing in tissues
or release in the circulation are unlikely to account for reduced
eosinophil uterine levels or for nonresponsiveness of eosinophils to
other chemotactic agents such as IL-5 in eotaxin-deficient mice. The
early detection of eotaxin mRNA at 5 wk of age was in line with the
infiltration of eosinophils in the pubertal uterus. In the absence of
eosinophils, there was a 2-wk delay in the onset of estrous cycles.
This finding could be the result of a defect of the
hypothalamic/pituitary axis or ovarian functions that are necessary for
a proper establishment of the onset of puberty (see Ref.
44 for review). However, the vaginal opening, which is
also regulated by the hypothalamic/pituitary axis, occurs at a similar
time in the eotaxin-deficient mice compared with wild-type mice. This
argues for a functional hypothalamic/pituitary axis in
eotaxin-deficient mice. Moreover, eosinophils are completely absent
from ovarian tissue of wild-type mice at puberty (at 5 and 7 wk of age,
data not shown), excluding a local role of eosinophils on
ovarian-dependent steroid hormonal levels, necessary for the onset of
puberty (see Ref. 44 for review). Thus, the delay of the
onset of estrous cycles in eotaxin-deficient mice, consistent with the
delay of the age of first parturition, does not seem to be due to a
systemic hormonal defect but rather suggests a local role of
eosinophils in the pubertal uterus in preparing the mature uterus for
pregnancy.
In contrast to this novel finding of the role of eosinophil in pubertal
uterine development, investigations into the role of the E-induced
infiltration of eosinophils into the uterine stroma during the estrus
cycle have been extensive. Because other events such as increases in
uterine growth, edema, protein synthesis, and epithelial C3 synthesis
are also E-dependent in cycling mice, it has been thought for long
time that uterine recruitment of eosinophils was directly associated
with these processes (20, 45, 46, 47, 48). However, our data show
very clearly that in the absence of eosinophils, the increase in wet
weight as a measure of uterine edema was not affected. Our observations
were consistent with others studies using different mouse models that
strongly depleted uterine eosinophils by using pertussis toxin-treated
mice, IL-5-deficient mice, or anti-IL-5 antibody-treated mice
(11, 25, 26). In the two last studies, increase of
complement C3 synthesis and changes in uterine morphology during estrus
cycle were not modified in relative absence of eosinophils. In
addition, a precise study of reproduction capacities of IL-5-deficient
mice indicated no major abnormality (26), as judged by a
normal estrus cycle length, although the estrus phase was significantly
longer in the mutant mice, and even though the time to observe the
copulatory plug in mutant mice was significantly reduced by 2 d,
the length of gestation and the outcomes of pregnancies were normal. In
our uterine eosinophil-free mouse model, displaying a different
background (129/SvEv), we confirmed the normal estrus cycle length and
litter size as well as the ability to have successive pregnancies
occurring at a normal frequency. Consequently, eosinophils do not have
a nonredundant role in regulating cyclicity in the adult uterus. This
surprising conclusion does still not rule out a potential role for
eotaxin in the estrous cycle, because, in humans, the eotaxin receptor
(CCR3) is not only expressed on eosinophils but also on endometrial
epithelial cells (30). If this is similar in mice, then
chemokines other than eotaxin that are known ligands for CCR3 (RANTES,
MCP-3) (49) could act directly on the luminal epithelium
to control the morphologic modifications occurring upon the estrus
cycle, even in absence of eosinophils.
In summary, in this study, we analyzed the uterus of eotaxin-deficient
mice, and identified eotaxin as the necessary E-induced chemokine for
eosinophil homing to the uterine stroma during puberty and adulthood.
Our data suggest that eosinophils have a local role in the pubertal
uterus in preparing the mature uterus for pregnancy but demonstrate
that these cells are not required for regulating the duration of the
estrous cycle and fertility of mice.
 |
Acknowledgments
|
|---|
We thank Dr. Marc E. Rothenberg for providing us the
eotaxin-deficient mice. We are grateful to Mr. Jim Lee for his
technical assistance in the mouse facility.
 |
Footnotes
|
|---|
This work was supported by NIH Grant R-O1-HD-30280, the Einstein Cancer
Center Grant P30-13330, and a DOD postdoctoral fellowship to Dr.
Valérie Gouon-Evans. (J.W.P. is the Sheldon and Betty E. Feinberg
Senior Faculty Scholar in Cancer Research.)
Abbreviations: ECF-U, Immature rat uterus of an eosinophil
chemotactic factor; TBS, Tris-buffered saline.
Received March 14, 2001.
Accepted for publication July 6, 2001.
 |
References
|
|---|
-
Marcus GJ 1974 Mitosis in the rat uterus
during the estrous cycle, early pregnancy, and early pseudopregnancy.
Biol Reprod 10:447452[Abstract]
-
Martin L, Finn CA, Trinder G 1973 Hypertrophy and
hyperplasia in the mouse uterus after oestrogen treatment: an
autoradiographic study. J Endocrinol 56:133144[Abstract/Free Full Text]
-
Finn CA, Martin L 1970 The role of the oestrogen
secreted before oestrus in the preparation of the uterus for
implantation in the mouse. J Endocrinol 47:431438
-
De M, Wood GW 1990 Influence of oestrogen and
progesterone on macrophage distribution in the mouse uterus. J
Endocrinol 126:417424[Abstract/Free Full Text]
-
Tchernitchin A, Roorijck J, Tchernitchin X, Vandenhende
J, Galand F 1974 Dramatic early increase in uterine eosinophils
after oestrogen administration. Nature 248:142143[CrossRef][Medline]
-
Hunt JS, Pollard JW 1992 Macrophages in the uterus
and placenta. Curr Top Microbiol Immunol 181:3963[Medline]
-
Hunt JS, Robertson SA 1996 Uterine macrophages and
environmental programming for pregnancy success. J Reprod Immunol 32:125[CrossRef][Medline]
-
Pollard JW, Lin EY, Zhu L 1998 Complexity in
uterine macrophage responses to cytokines in mice. Biol Reprod 58:14691475[Abstract/Free Full Text]
-
Bassett EG 1962 Infiltration of eosinophils into
the modified connective tissue of oestrous and pregnant animals. Nature
(London) 194:12591261[CrossRef]
-
Ross R, Klebanoff SJ 1966 The eosinophilic
leukocyte. Fine structure studies of changes in the uterus during the
estrous cycle. J Exp Med 124:653660[Abstract]
-
Zheng Y, Zhou ZZ, Lyttle CR, Teuscher C 1988 Immunohistochemical characterization of the estrogen-stimulated
leukocyte influx in the immature rat uterus. J Leukoc Biol 44:2732[Abstract]
-
Gansler H 1956 Elektronenmikroskopische
untersuchungen am uterusmuskel der ratte unter follikelhormonwirkung.
Virchows Arch 329:235244
-
Salamonsen LA, Woolley DE 1999 Menstruation:
induction by matrix metalloproteinases and inflammatory cells. J Reprod
Immunol 44:127[CrossRef][Medline]
-
Pepper H, Lindsay S 1960 Levels of eosinophils,
platelets, leukocytes, and 17-hydroxycorticosteroids during normal
menstrual cycle. Proc Soc Exp Biol Med 104:145147
-
Lucas FV, Neufeld HA, Utterback JG, Martin AP, Stotz
E 1955 The effect of estrogen on the production of a peroxidase in
the rat uterus. J Biol Chem 214:775780[Free Full Text]
-
Keeping HS, Lyttle CR 1984 Monoclonal antibody to
rat uterine peroxidase and its use in identification of the peroxidase
as being of eosinophil origin. Biochim Biophys Acta 802:399406[Medline]
-
King WJ, Allen TC, DeSombre ER 1981 Localization of
uterine peroxidase activity in estrogen-treated rats. Biol Reprod 25:859870[Abstract]
-
Rytomaa T 1960 Organ distribution and histochemical
properties of eosinophil granulocyte in rat. Acta Pathol Microbiol
Scand 50(Suppl 140):1118
-
Kelenyi G, Nemeth A 1972 Tissue eosinophil
leucocytes. II. Electron microscopy and histochemistry of the uterine
eosinophil leucocytes in oestrogen-treated spayed rats. Acta Biol Acad
Sci Hung 23:253267
-
Tchernitchin A, Tchernitchin X, Galand P 1975 Correlation of estrogen-induced uterine eosinophilia with other
parameters of estrogen stimulation, produced with estradiol-17ß and
estriol. Experientia 31:993994[CrossRef][Medline]
-
Sanderson CJ 1992 Interleukin-5, eosinophils, and
disease. Blood 79:31013109[Free Full Text]
-
Jose PJ, Griffiths-Johnson DA, Collins PD, et al. 1994 Eotaxin: a potent eosinophil chemoattractant cytokine detected in
a guinea pig model of allergic airways inflammation. J Exp Med 179:881887[Abstract/Free Full Text]
-
Ponath PD, Qin S, Ringler DJ, et al. 1996 Cloning
of the human eosinophil chemoattractant, eotaxin: expression, receptor
binding, and functional properties suggest a mechanism for the
selective recruitment of eosinophils. J Clin Invest 97:604612[Medline]
-
Coffman RL, Seymour BW, Hudak S, Jackson J, Rennick
D 1989 Antibody to interleukin-5 inhibits helminth-induced
eosinophilia in mice. Science 245:308310[Abstract/Free Full Text]
-
Perez MC, Furth EE, Matzumura PD, Lyttle CR 1996 Role of eosinophils in uterine responses to estrogen. Biol Reprod 54:249254[Abstract]
-
Robertson SA, Mau VJ, Young IG, Matthaei KI 2000 Uterine eosinophils and reproductive performance in interleukin
5-deficient mice. J Reprod Fertil 120:423432[Abstract]
-
Rothenberg ME, Luster AD, Lilly CM, Drazen JM, Leder
P 1995 Constitutive and allergen-induced expression of eotaxin
mRNA in the guinea pig lung. J Exp Med 181:12111216[Abstract/Free Full Text]
-
Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J,
Leder P, Luster AD 1996 Human eotaxin is a specific
chemoattractant for eosinophil cells and provides a new mechanism to
explain tissue eosinophilia. Nat Med 2:449456[CrossRef][Medline]
-
Gouon-Evans V, Rothenberg ME, Pollard JW 2000 Postnatal mammary gland development requires macrophages and
eosinophils. Development 127:22692282[Abstract]
-
Zhang J, Lathbury LJ, Salamonsen LA 2000 Expression
of the chemokine eotaxin and its receptor, CCR3, in human
endometrium. Biol Reprod 62:404411[Abstract/Free Full Text]
-
Rothenberg ME, MacLean JA, Pearlman E, Luster AD, Leder
P 1997 Targeted disruption of the chemokine eotaxin partially
reduces antigen- induced tissue eosinophilia. J Exp Med 185:785790[Abstract/Free Full Text]
-
Chomczynski P, Sacchi N 1987 Single-step method of
RNA isolation by acid guanidinium thiocyanate- phenol-chloroform
extraction. Anal Biochem 162:156159[Medline]
-
Arceci RJ, Shanahan F, Stanley ER, Pollard JW 1989 Temporal expression and location of colony-stimulating factor 1 (CSF-1)
and its receptor in the female reproductive tract are consistent with
CSF-1-regulated placental development. Proc Natl Acad Sci USA 86:88188822[Abstract/Free Full Text]
-
Rothenberg ME, Luster AD, Leder P 1995 Murine
eotaxin: an eosinophil chemoattractant inducible in endothelial cells
and in interleukin 4-induced tumor suppression. Proc Natl Acad Sci USA 92:89608964[Abstract/Free Full Text]
-
Brody JR, Cunha GR 1989 Histologic, morphometric,
and immunocytochemical analysis of myometrial development in rats and
mice: I. Normal development. Am J Anat 186:120[CrossRef][Medline]
-
Emmens CW, Martin L 1964 Anti-estrogens. In:
Dorfman RI, ed. Methods in hormone research. New York: Academic Press,
vol III; 81125
-
Lee YH, Howe RS, Sha SJ, Teuscher C, Sheehan DM, Lyttle
CR 1989 Estrogen regulation of an eosinophil chemotactic factor in
the immature rat uterus. Endocrinology 125:30223028[Abstract]
-
Xu Q, Leiva MC, Fischkoff SA, Handschumacher RE, Lyttle
CR 1992 Leukocyte chemotactic activity of cyclophilin. J Biol
Chem 267:1196811971[Abstract/Free Full Text]
-
Fischer G, Tradler T, Zarnt T 1998 The mode of
action of peptidyl prolyl cis/trans isomerases in vivo: binding vs.
catalysis. FEBS Lett 426:1720[CrossRef][Medline]
-
Robertson SA, Allanson M, Mau VJ 1998 Molecular
regulation of uterine leukocyte recruitment during early pregnancy in
the mouse. Trophoblast Res 11:101119
-
Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ,
Williams TJ 1995 Cooperation between interleukin-5 and the
chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 182:11691174[Abstract/Free Full Text]
-
Rothenberg ME, Ownbey R, Mehlhop PD, et al. 1996 Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a
distinct receptor and induces pulmonary eosinophilia in the presence of
interleukin 5 in mice. Mol Med 2:334348[Medline]
-
Mishra A, Hogan SP, Lee JJ, Foster PS, Rothenberg
ME 1999 Fundamental signals that regulate eosinophil homing to the
gastrointestinal tract. J Clin Invest 103:17191727[Medline]
-
Ojeda SR, Urbanski HF, Ahmed CE 1986 The onset of
female puberty: studies in the rat. Recent Prog Horm Res 42:385442
-
Sundstrom SA, Komm BS, Ponce-de-Leon H, Yi Z, Teuscher
C, Lyttle CR 1989 Estrogen regulation of tissue-specific
expression of complement C3. J Biol Chem 264:1694116947[Abstract/Free Full Text]
-
Komm BS, Rusling DJ, Lyttle CR 1986 Estrogen
regulation of protein synthesis in the immature rat uterus: the
analysis of proteins released into the medium during in
vitro incubation. Endocrinology 118:24112416[Abstract]
-
Kuivanen PC, DeSombre ER 1985 The effects of
sequential administration of 17ß-estradiol on the synthesis and
secretion of specific proteins in the immature rat uterus. J Steroid
Biochem 22:439451[CrossRef][Medline]
-
Takeda A, Takahashi N, Shimizu S 1988 Identification and characterization of an estrogen-inducible
glycoprotein (uterine secretory protein-1) synthesized and secreted by
rat uterine epithelial cells. Endocrinology 122:105113[Abstract]
-
Ponath PD, Qin S, Post TW, Wang J, Wu L, Gerard NP,
Newman W, Gerard C, Mackay CR 1996 Molecular cloning and
characterization of a human eotaxin receptor expressed selectively on
eosinophils. J Exp Med 183:24372448[Abstract/Free Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
W. V. Ingman and R. L. Jones
Cytokine knockouts in reproduction: the use of gene ablation to dissect roles of cytokines in reproductive biology
Hum. Reprod. Update,
March 1, 2008;
14(2):
179 - 192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Salati, E. Bianchi, R. Zini, E. Tenedini, D. Quaglino, R. Manfredini, and S. Ferrari
Eosinophils, but not neutrophils, exhibit an efficient DNA repair machinery and high nucleolar activity
Haematologica,
October 1, 2007;
92(10):
1311 - 1318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Naciff, G. J. Overmann, S. M. Torontali, G. J. Carr, Z. S. Khambatta, J. P. Tiesman, B. D. Richardson, and G. P. Daston
Uterine Temporal Response to Acute Exposure to 17{alpha}-Ethinyl Estradiol in the Immature Rat
Toxicol. Sci.,
June 1, 2007;
97(2):
467 - 490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Pan, L. Zhu, Y. Deng, and J. W. Pollard
Microarray Analysis of Uterine Epithelial Gene Expression during the Implantation Window in the Mouse
Endocrinology,
October 1, 2006;
147(10):
4904 - 4916.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Niklaus and J. W. Pollard
Mining the Mouse Transcriptome of Receptive Endometrium Reveals Distinct Molecular Signatures for the Luminal and Glandular Epithelium
Endocrinology,
July 1, 2006;
147(7):
3375 - 3390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Kwekel, L. D. Burgoon, J. W. Burt, J. R. Harkema, and T. R. Zacharewski
A cross-species analysis of the rodent uterotrophic program: elucidation of conserved responses and targets of estrogen signaling
Physiol Genomics,
November 17, 2005;
23(3):
327 - 342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Chaves-Pozo, V. Mulero, J. Meseguer, and A. G. Ayala
Professional phagocytic granulocytes of the bony fish gilthead seabream display functional adaptation to testicular microenvironment
J. Leukoc. Biol.,
August 1, 2005;
78(2):
345 - 351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C. Fertuck, J. E. Eckel, C. Gennings, and T. R. Zacharewski
Identification of temporal patterns of gene expression in the uteri of immature, ovariectomized mice following exposure to ethynylestradiol
Physiol Genomics,
October 17, 2003;
15(2):
127 - 141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Barber and J. W. Pollard
The Uterine NK Cell Population Requires IL-15 but These Cells Are Not Required for Pregnancy nor the Resolution of a Listeria monocytogenes Infection
J. Immunol.,
July 1, 2003;
171(1):
37 - 46.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. Sferruzzi-Perri, S. A. Robertson, and L. A. Dent
Interleukin-5 Transgene Expression and Eosinophilia Are Associated with Retarded Mammary Gland Development in Mice
Biol Reprod,
July 1, 2003;
69(1):
224 - 233.
[Abstract]
[Full Text]
[PDF]
|
 |
|